BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 30942510)

  • 1. The effect of hydroalcoholic Saffron (Crocus sativus L.) extract on fasting plasma glucose, HbA1c, lipid profile, liver, and renal function tests in patients with type 2 diabetes mellitus: A randomized double-blind clinical trial.
    Moravej Aleali A; Amani R; Shahbazian H; Namjooyan F; Latifi SM; Cheraghian B
    Phytother Res; 2019 Jun; 33(6):1648-1657. PubMed ID: 30942510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of saffron (Crocus sativus L.) on glycemia, lipid profile, and antioxidant status in patients with type-2 diabetes mellitus: A randomized placebo-controlled trial.
    Tajaddini A; Roshanravan N; Mobasseri M; Haleem Al-Qaim Z; Hadi A; Aeinehchi A; Sefid-Mooye Azar P; Ostadrahimi A
    Phytother Res; 2023 Feb; 37(2):388-398. PubMed ID: 36580575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saffron improves life and sleep quality, glycaemic status, lipid profile and liver function in diabetic patients: A double-blind, placebo-controlled, randomised clinical trial.
    Tajaddini A; Roshanravan N; Mobasseri M; Aeinehchi A; Sefid-Mooye Azar P; Hadi A; Ostadrahimi A
    Int J Clin Pract; 2021 Aug; 75(8):e14334. PubMed ID: 33960081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial.
    Hosseini S; Jamshidi L; Mehrzadi S; Mohammad K; Najmizadeh AR; Alimoradi H; Huseini HF
    J Ethnopharmacol; 2014 Mar; 152(3):451-6. PubMed ID: 24462785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of saffron (Crocus sativus L.) on lipid profile, glycemic indices and antioxidant status among overweight/obese prediabetic individuals: A double-blinded, randomized controlled trial.
    Karimi-Nazari E; Nadjarzadeh A; Masoumi R; Marzban A; Mohajeri SA; Ramezani-Jolfaie N; Salehi-Abargouei A
    Clin Nutr ESPEN; 2019 Dec; 34():130-136. PubMed ID: 31677703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.
    Ranasinghe P; Galappaththy P; Constantine GR; Jayawardena R; Weeratunga HD; Premakumara S; Katulanda P
    Trials; 2017 Sep; 18(1):446. PubMed ID: 28962661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Satureja Khuzestanica supplementation on glycemic indices and lipid profile in type 2 diabetes patients: a randomized controlled clinical-trial.
    Roosta S; Ghasemi F; Mokhayeri Y; Choobkar S; Nikbakht MR; Falahi E
    BMC Complement Med Ther; 2024 May; 24(1):201. PubMed ID: 38778308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effects of Hydroalcoholic Extract of Saffron in Alleviating Experimental Autoimmune Diabetes in C57bl/6 Mice.
    Faridi S; Delirezh N; Abtahi Froushani SM
    Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):38-47. PubMed ID: 30848572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    Phytomedicine; 2021 Jan; 81():153431. PubMed ID: 33352495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2.
    Mang B; Wolters M; Schmitt B; Kelb K; Lichtinghagen R; Stichtenoth DO; Hahn A
    Eur J Clin Invest; 2006 May; 36(5):340-4. PubMed ID: 16634838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial.
    Akilen R; Tsiami A; Devendra D; Robinson N
    Diabet Med; 2010 Oct; 27(10):1159-67. PubMed ID: 20854384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of saffron (
    Milajerdi A; Jazayeri S; Hashemzadeh N; Shirzadi E; Derakhshan Z; Djazayeri A; Akhondzadeh S
    J Res Med Sci; 2018; 23():16. PubMed ID: 29531568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
    Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
    Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
    Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
    Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
    Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial.
    Kianbakht S; Dabaghian FH
    Complement Ther Med; 2013 Oct; 21(5):441-6. PubMed ID: 24050577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial.
    Huseini HF; Hasani-Rnjbar S; Nayebi N; Heshmat R; Sigaroodi FK; Ahvazi M; Alaei BA; Kianbakht S
    Complement Ther Med; 2013 Oct; 21(5):447-52. PubMed ID: 24050578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.